Thus, considering these clinical data, and the presence of B7-H6 in certain cancers including oral cancers, and its ability to modulate immune cell function that can be exploited in immunotherapeutic approaches, we selected this molecule as a further OSCC biomarker to detect in our system. The gene discussed is NCR3LG1; the disease is cancer.